Makoto Okuya

992 total citations
32 papers, 596 citations indexed

About

Makoto Okuya is a scholar working on Psychiatry and Mental health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Makoto Okuya has authored 32 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Makoto Okuya's work include Bipolar Disorder and Treatment (17 papers), Schizophrenia research and treatment (13 papers) and Electroconvulsive Therapy Studies (9 papers). Makoto Okuya is often cited by papers focused on Bipolar Disorder and Treatment (17 papers), Schizophrenia research and treatment (13 papers) and Electroconvulsive Therapy Studies (9 papers). Makoto Okuya collaborates with scholars based in Japan and United States. Makoto Okuya's co-authors include Taro Kishi, Nakao Iwata, Kenji Sakuma, Toshikazu Ikuta, Yuki Matsuda, Ikuo Nomura, Masakazu Hatano, Kazuo Mishima, Shinji Matsunaga and Nobumi Miyake and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychological Medicine and Molecular Psychiatry.

In The Last Decade

Makoto Okuya

30 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makoto Okuya Japan	12	282	133	130	107	79	32	596
Ken Inada Japan	17	262 0.9×	74 0.6×	118 0.9×	128 1.2×	63 0.8×	78	763
Nicolás A. Núñez United States	14	265 0.9×	138 1.0×	103 0.8×	65 0.6×	115 1.5×	55	711
Nicholas Rosenlicht United States	11	181 0.6×	166 1.2×	175 1.3×	191 1.8×	75 0.9×	14	577
Vasilios G. Masdrakis Greece	14	248 0.9×	142 1.1×	137 1.1×	55 0.5×	57 0.7×	45	535
Andrea Edit Édes Hungary	12	157 0.6×	67 0.5×	64 0.5×	94 0.9×	45 0.6×	20	403
John J. Worthington United States	6	209 0.7×	212 1.6×	95 0.7×	88 0.8×	102 1.3×	6	487
Anna Sparshatt United Kingdom	13	405 1.4×	150 1.1×	60 0.5×	38 0.4×	71 0.9×	16	581
Ayako Kaneda Japan	15	167 0.6×	80 0.6×	99 0.8×	83 0.8×	42 0.5×	42	533
Karl Burgoyne United States	12	368 1.3×	257 1.9×	104 0.8×	182 1.7×	64 0.8×	20	717
Tatjana Dose Germany	7	174 0.6×	196 1.5×	65 0.5×	46 0.4×	177 2.2×	10	658

Countries citing papers authored by Makoto Okuya

Since Specialization

Citations

This map shows the geographic impact of Makoto Okuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Okuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Okuya more than expected).

Fields of papers citing papers by Makoto Okuya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Okuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Okuya. The network helps show where Makoto Okuya may publish in the future.

Co-authorship network of co-authors of Makoto Okuya

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Okuya. A scholar is included among the top collaborators of Makoto Okuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Okuya. Makoto Okuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kishi, Taro, Kenji Sakuma, Masakazu Hatano, Makoto Okuya, & Nakao Iwata. (2023). Early relapse after antidepressant discontinuation may represent antidepressant discontinuation syndrome in major depressive disorder: A meta-analysis. Asian Journal of Psychiatry. 82. 103502–103502. 2 indexed citations

Sakuma, Kenji, Taro Kishi, Ikuo Nomura, et al.. (2023). Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis. Psychiatry and Clinical Neurosciences. 77(5). 297–299.

Kishi, Taro, Toshikazu Ikuta, Kenji Sakuma, et al.. (2022). Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Molecular Psychiatry. 28(1). 402–409. 71 indexed citations

Kishi, Taro, Kenji Sakuma, Masakazu Hatano, et al.. (2022). Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression. Molecular Psychiatry. 28(3). 974–976. 10 indexed citations

Kishi, Taro, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, & Nakao Iwata. (2021). Duration of long‐acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia. Psychiatry and Clinical Neurosciences. 75(7). 240–241. 1 indexed citations

Kishi, Taro, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, & Nakao Iwata. (2021). Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review. Neuropsychopharmacology Reports. 41(3). 422–425. 2 indexed citations

Kishi, Taro, Yuki Matsuda, Kenji Sakuma, et al.. (2021). Recurrence Rates in Stable Bipolar Disorder Patients after Drug Discontinuation versus Drug Maintenance: A Systematic Review and Meta-analysis – Corrigendum. Psychological Medicine. 51(15). 2730–2730. 1 indexed citations

Kishi, Taro, Kenji Sakuma, Makoto Okuya, Masashi Ikeda, & Nakao Iwata. (2021). Omega‐3 fatty acids for treating residual depressive symptoms in adult patients with bipolar disorder: A systematic review and meta‐analysis of double‐blind randomized, placebo‐controlled trials. Bipolar Disorders. 23(7). 730–731. 7 indexed citations

Kishi, Taro, Toshikazu Ikuta, Kenji Sakuma, Makoto Okuya, & Nakao Iwata. (2021). Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan. Journal of Psychiatric Research. 138. 444–452. 13 indexed citations

10.

Kishi, Taro, Kenji Sakuma, Makoto Okuya, et al.. (2021). Effects of a conventional mood stabilizer alone or in combination with second‐generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta‐analysis of randomized, placebo‐controlled trials. Bipolar Disorders. 23(8). 789–800. 11 indexed citations

11.

Kishi, Taro, Michinori Koebis, Kenzo Muramoto, et al.. (2021). Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review. Neuropsychopharmacology Reports. 41(4). 450–458. 21 indexed citations

12.

Kishi, Taro, Nobumi Miyake, Makoto Okuya, Kenji Sakuma, & Nakao Iwata. (2020). N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials. Psychopharmacology. 237(11). 3481–3487. 27 indexed citations

13.

Kishi, Taro, Kenji Sakuma, Makoto Okuya, & Nakao Iwata. (2020). Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia. Journal of Psychiatric Research. 132. 144–150. 3 indexed citations

14.

Kishi, Taro, Kenji Sakuma, Makoto Okuya, et al.. (2020). Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium. Journal of Clinical Psychopharmacology. 40(5). 468–474. 4 indexed citations

15.

Kishi, Taro, Yuki Matsuda, Kenji Sakuma, et al.. (2020). Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis. Psychological Medicine. 51(15). 2721–2729. 21 indexed citations

16.

Kishi, Taro, Yuki Matsuda, Kenji Sakuma, Makoto Okuya, & Nakao Iwata. (2020). Factors associated with discontinuation in the drug and placebo groups of trials of second generation antipsychotics for acute schizophrenia: A meta-regression analysis. Journal of Psychiatric Research. 130. 240–246. 2 indexed citations

17.

Kishi, Taro, Ikuo Nomura, Yuki Matsuda, et al.. (2020). Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis. Journal of Psychiatric Research. 128. 68–74. 66 indexed citations

18.

Kishi, Taro, Reiji Yoshimura, Kenji Sakuma, Makoto Okuya, & Nakao Iwata. (2020). Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan. Neuropsychopharmacology Reports. 40(4). 417–422. 7 indexed citations

19.

Sakuma, Kenji, Shinji Matsunaga, Ikuo Nomura, et al.. (2018). Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis. Psychopharmacology. 235(8). 2303–2314. 15 indexed citations

20.

Kishi, Taro, Kazuto Oya, Yuki Matsui, et al.. (2018). Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials. Neuropsychiatric Disease and Treatment. Volume 14. 2519–2530. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact